Trial record 2 of 3 for:    Cellerant

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01297543
Recruitment Status : Completed
First Posted : February 16, 2011
Last Update Posted : July 1, 2016
Department of Health and Human Services
Information provided by (Responsible Party):
Cellerant Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2014
  Actual Study Completion Date : January 2015
  Certification/Extension First Submitted : May 10, 2016